Literature DB >> 1968760

K20 and ICO-10 monoclonal antibodies (gp120/200; Thy-1): immunophenotyping of human solid tumours.

Z G Kadagidze1, N N Tupitsyn, A J Baryshnikov, K P Kadyrov, V M Blinov, A Bernard, M Amiot, L Boumsell.   

Abstract

Solid tumour cells were shown to express VLA-beta and Thy-1 antigens. For identification of these molecules two monoclonal antibodies, K-20 and ICO-10, characterised in detail previously, were used. Four groups of solid tumours have been identified according to their immunophenotype: VLA-beta+ and Thy-1-; VLA-beta+ and Thy-1+; VLA-beta- and Thy-1+; VLA-beta- and Thy-1-. To a certain extent these groups have been shown to reflect tumour histogenesis: tumours of epithelial origin never expressed an ICO-10+, K20-phenotype while soft tissue sarcomas and neuroblastoma cells never expressed the beta-chain of VLA molecular complexes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968760      PMCID: PMC1971397          DOI: 10.1038/bjc.1990.39

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  8 in total

1.  Suppressor effects and cyclic AMP accumulation by the CD29 molecule of CD4+ lymphocytes.

Authors:  H Groux; S Huet; H Valentin; D Pham; A Bernard
Journal:  Nature       Date:  1989-05-11       Impact factor: 49.962

2.  The human cell surface glycoprotein complex (gp 120,200) recognized by monoclonal antibody K20 is a component binding to phytohaemagglutinin on T cells.

Authors:  M Amiot; A Bernard; H C Tran; G Leca; J M Kanellopoulos; L Boumsell
Journal:  Scand J Immunol       Date:  1986-01       Impact factor: 3.487

3.  Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody.

Authors:  R C Seeger; Y L Danon; S A Rayner; F Hoover
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

4.  Fetal neural antigens on human neuroblastoma cells.

Authors:  Y L Danon; R C Seeger; J E Maidman
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

5.  Human Thy-1 antigen: cell surface expression on early T and B lymphocytes.

Authors:  M A Ritter; C A Sauvage; D Delia
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

6.  Reactivity of human brain antiserum with neuroblastoma cells and nonreactivity with thymocytes and lymphoblasts.

Authors:  J T Casper; L Borella; L Sen
Journal:  Cancer Res       Date:  1977-06       Impact factor: 12.701

7.  Human thy-1: unusual localization and possible functional significance in lymphoid tissues.

Authors:  J L McKenzie; J W Fabre
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

8.  Role of human chromosome 11 in determining surface antigenic phenotype of normal and malignant cells. Somatic cell genetic analysis of eight antigens, including putative human Thy-1.

Authors:  W J Rettig; N C Dracopoli; P G Chesa; B A Spengler; H R Beresford; P Davies; J L Biedler; L J Old
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

  8 in total
  2 in total

1.  Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases.

Authors:  K Koretz; P Schlag; L Boumsell; P Möller
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

2.  Differential expression of beta 1 integrins in nonneoplastic smooth and striated muscle cells and in tumors derived from these cells.

Authors:  G Mechtersheimer; T Barth; A Quentmeier; P Möller
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.